Skip to main content
. Author manuscript; available in PMC: 2010 Mar 25.
Published in final edited form as: J Infect Dis. 2008 Nov 1;198(9):1407–1414. doi: 10.1086/592222

Figure 1.

Figure 1

Effect of eukaryotic translation initiation factor 5A (eIF5A) small interference RNA (siRNA) on the survival of BALB/c and C57BL/6 mice after intraperitoneal challenge with lipopolysaccharide (LPS). BALB/c mice were treated intraperitoneally with 50 µg of eIF5A siRNA at the time of and/or before (A) or at the time of and/or after (B) intraperitoneal challenge with 5 mg/kg LPS (n = 5–11 mice per group). C57BL/6 mice were treated intraperitoneally with 50 µg of eIF5A siRNA at the time of and/or before (C) or at the time of and/or after (D) intraperitoneal challenge with 25 mg/kg LPS (n = 5–7 mice per group).